NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $17,677,350 | -20.9% | 241,000 | -66.2% | 3.46% | +11.9% |
Q2 2018 | $22,348,000 | -99.9% | 713,998 | -5.2% | 3.10% | +27.0% |
Q1 2018 | $16,426,000,000 | +92378.3% | 753,481 | -14.3% | 2.44% | -19.5% |
Q4 2017 | $17,762,000 | +403.6% | 879,286 | +394.9% | 3.03% | +341.8% |
Q3 2017 | $3,527,000 | – | 177,666 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |